The text discusses a rare case of Kawasaki Disease (KD) in an adult following COVID-19 vaccination with Vaxzevria. KD is a rare autoimmune disease characterized by vasculitis, and the patient presented with atypical symptoms such as liver and renal involvement. The case highlights the importance of monitoring and reporting adverse events following immunization (AEFI) to ensure vaccine safety. The patient received treatment with IV immunoglobulin and aspirin, showing a good response. The diagnosis was classified as indeterminate in terms of causality related to immunization. The text emphasizes the need for continued vigilance in monitoring vaccine safety and encourages clinicians to be aware of potential rare events following vaccination.